Announcements Trials
Browse Landscape

Phase

Phase 1 41Phase NA 17Phase 1/2 11Phase 2 9Phase 3 3Phase EARLY_PHASE1 2Phase 4 1Phase 2/3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 118Breast 8Gastrointestinal 5Plasma cell 2NET 2Endocrine 2Dermatologic 2Thoracic 1Sarcoma 1Other 1Gynecologic 1Classical hematology 1

Conditions

Gastrointestinal Stromal Tumors 10Bone Neoplasms 9Sarcoma 8Neoplasms 3Multiple Myeloma 3Sarcoma, Kaposi 2Rhabdomyosarcoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pain 2Osteosarcoma 2Neoplasm Metastasis 2Lymphoma 2Carcinoma, Renal Cell 2Breast Neoplasms 2Anemia 2Acquired Immunodeficiency Syndrome 2Waldenstrom Macroglobulinemia 1Venous Thromboembolism 1Stomach Neoplasms 1Sarcoma, Ewing 1Rhabdomyosarcoma, Alveolar 1Renal Insufficiency 1Recurrence 1Rectal Neoplasms 1Psoriasis 1Prostatic Neoplasms 1Progressive Gastrointestinal Stromal Tumor 1Piebaldism 1Pancreatic Neoplasms 1Pain, Intractable 1

Interventions

Zoledronic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Prostatic Neoplasms × Sarcoma × Clear all
NCT00434447 2017-02-27

Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases

Novartis

Phase 4 Completed
73 enrolled
BreastGenitourinaryPlasma cellSarcoma

Bone Neoplasms, Breast Neoplasms, Multiple Myeloma, Prostatic Neoplasms, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡